Phibro Animal Health Corporation Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Phibro Animal Health Corporation (PAHC) holds an ST Score of 55.2 out of 100 (B-), with its strongest factor being Sentiment (A+) and its weakest Valuation (D). Analysts rate PAHC Buy across 14 ratings with a $28.00 average price target (-0.2% vs the current $35.15).
- Strongest
- SentimentA+
- Weakest
- ValuationD
All factor grades
- SentimentA+
- ProfitabilityA
- MomentumB-
- GrowthB-
- ForecastC
- Financial StrengthD+
- ValuationD
- Piotroski6/9
Contact
PAHC stock: frequently asked questions
What is PAHC's ST Score?
Phibro Animal Health Corporation (PAHC) has an ST Score of 55.2 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PAHC a buy, sell, or hold?
Wall Street's consensus rating on PAHC is Buy based on 14 analyst ratings. Our own ST Score grades it B- (55.2/100). This is data, not investment advice — always do your own research.
What is PAHC's valuation grade?
Phibro Animal Health Corporation (PAHC) earns a valuation grade of D, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PAHC's growth grade?
Phibro Animal Health Corporation (PAHC) earns a growth grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PAHC's profitability grade?
Phibro Animal Health Corporation (PAHC) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PAHC's financial strength grade?
Phibro Animal Health Corporation (PAHC) earns a financial strength grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PAHC?
The average analyst price target for Phibro Animal Health Corporation (PAHC) is $28.00 from 14 analysts, which is -0.2% versus the recent price of $35.15.
What is PAHC's Piotroski score?
Phibro Animal Health Corporation (PAHC) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.